Development of selective inhibitors for the treatment of rheumatoid arthritis: (R)-3-(3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor.

Publication

Citation: Chough C, Joung M, Lee S, Lee J, Kim JH, Kim BM.: Development of selective inhibitors for the treatment of rheumatoid arthritis: (R)-3-(3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)-3-oxopropanenitrile as a JAK1-selective inhibitor. Bioorg Med Chem, Volume 26 (8), 2018
Authors: Chough C, Joung M, Kim BM., Kim JH, Lee J, Lee S
Journal: Bioorg Med Chem
Year: 2018
DOI: 10.1016/j.bmc.2018.01.021
PubMed: 29452839
Machine-readable: REST API RDF